Literature DB >> 556828

Plasma anticonvulsant concentrations during pregnancy.

C M Lander, V E Edwards, M J Eadie, J H Tyrer.   

Abstract

Plasma anticonvulsant levels were followed during pregnancy in 11 epileptic women taking phenytoin and/or phenobarbital or a drug metabolized in the body to phenobarbital. As judged from the relationship between plasma level and drug dose, phenytoin requirement increased in all 10 women taking this drug during pregnancy. The requirement fell again in the puerperium. Plasma phenobarbital levels decreased during pregnancy in all five women taking a constant daily dose of phenobarbital or a congener. These findings should be borne in mind if epileptics are to be protected against seizures during pregnancy and against anticonvulsant overdosage during the puerperium.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 556828     DOI: 10.1212/wnl.27.2.128

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  22 in total

1.  Plasma drug level monitoring in pregnancy.

Authors:  M J Eadie; C M Lander; J H Tyrer
Journal:  Clin Pharmacokinet       Date:  1977 Nov-Dec       Impact factor: 6.447

2.  Comparison of the pharmacokinetics of cephradine and cefazolin in pregnant and non-pregnant women.

Authors:  A Philipson; G Stiernstedt; M Ehrnebo
Journal:  Clin Pharmacokinet       Date:  1987-02       Impact factor: 6.447

3.  Plasma concentration-effect relationship of metoprolol during and after pregnancy.

Authors:  S Högstedt; A Rane
Journal:  Eur J Clin Pharmacol       Date:  1993       Impact factor: 2.953

4.  Plasma concentrations of carbamazepine and carbamazepine 10,11-epoxide during pregnancy and after delivery.

Authors:  D Battino; S Binelli; L Bossi; R Canger; D Croci; C Cusi; M De Giambattista; G Avanzini
Journal:  Clin Pharmacokinet       Date:  1985 May-Jun       Impact factor: 6.447

Review 5.  Anticonvulsants during pregnancy and lactation. Transplacental, maternal and neonatal pharmacokinetics.

Authors:  H Nau; W Kuhnz; H J Egger; D Rating; H Helge
Journal:  Clin Pharmacokinet       Date:  1982 Nov-Dec       Impact factor: 6.447

6.  Increased oral clearance of metoprolol in pregnancy.

Authors:  S Högstedt; B Lindberg; A Rane
Journal:  Eur J Clin Pharmacol       Date:  1983       Impact factor: 2.953

7.  Serum protein binding and free concentration of phenytoin and phenobarbitone in pregnancy.

Authors:  S S Chen; E Perucca; J N Lee; A Richens
Journal:  Br J Clin Pharmacol       Date:  1982-04       Impact factor: 4.335

Review 8.  Use of benzodiazepines during pregnancy, labour and lactation, with particular reference to pharmacokinetic considerations.

Authors:  J H Kanto
Journal:  Drugs       Date:  1982-05       Impact factor: 9.546

Review 9.  Anticonvulsant drugs. An update.

Authors:  M J Eadie
Journal:  Drugs       Date:  1984-04       Impact factor: 9.546

Review 10.  Plasma level monitoring of anticonvulsants.

Authors:  M J Eadie
Journal:  Clin Pharmacokinet       Date:  1976       Impact factor: 6.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.